Risk and Volatility
Carmell has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.
Earnings & Valuation
This table compares Carmell and Titan Medical”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Carmell | $32,839.00 | 301.43 | -$15.44 million | ($0.46) | -1.03 |
| Titan Medical | $17.63 million | 2.98 | $6.95 million | $0.05 | 9.22 |
Insider and Institutional Ownership
24.2% of Carmell shares are held by institutional investors. Comparatively, 0.0% of Titan Medical shares are held by institutional investors. 29.0% of Carmell shares are held by company insiders. Comparatively, 0.0% of Titan Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Carmell and Titan Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Carmell | N/A | -217.50% | -50.22% |
| Titan Medical | N/A | -82.31% | -51.47% |
Summary
Titan Medical beats Carmell on 6 of the 10 factors compared between the two stocks.
About Carmell
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.
About Titan Medical
Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.
